Why the study?
Clinical and hemodynamic outcomes of the epoxy-treated xenopericardial bioprosthesis UniLine for isolated mitral, aortic, and tricuspid valve disease required analysis.
The UniLine xenopericardial bioprosthesis demonstrated excellent mid-term safety, 100% 3-year survival, and stable hemodynamics after aortic, mitral, or tricuspid valve replacement.
Supports short-term safety of UniLine bioprosthesis after valve replacement; leaves open long-term durability and randomized confirmation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Abdulyanov et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: